Iterion Therapeutics Iterion Therapeutics is a clinical-stage biotechnology company developing targeted cancer therapeutics. | ![]() Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients. | ![]() Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases. | |||
Founding Date | Founding Date 2014 | Founding Date 2011 | Founding Date 1995 | Founding Date 2006 | Founding Date 2005 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Houston, US HQ | Locations Lebanon, US HQ Alton, US | Locations Seattle, US HQ Vancouver, CA Bothell, US Bothell, US | Locations New York, US HQ Reno, US | Locations Houston, US HQ San Diego, US |
Employees | Employees 16 | Employees 3 | Employees 148% increase | Employees 1623% increase | Employees 3 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 166.2 m | Valuation ($) 484.6 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($39.8m) (FY, 2024) | Net income ($43m) (FY, 2024) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 2.6m (almost 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 15.5m (over 6 years ago) |
Total funding raised | Total funding raised $ 4.4m | Total funding raised N/A | Total funding raised $ 10m | Total funding raised $ 12.6m | Total funding raised $ 54.2m |
ImmuNext is a biotech company that develops immunotherapies
View companyAchieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.
View companyAnavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
View companyDNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.
View company